GE HealthCare Technologies Inc. (GEHC)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $37.51B
Last updated: Nov 17, 2026 at 4:41 PM ET
GE HealthCare Technologies Inc. (GEHC) Statistics
GE HealthCare Technologies (GEHC) has a market cap of $37.51B and an enterprise value of $44.63B. Its return on invested capital of 11.86% compares with a 7.46% median across 10 similar companies.
Total Valuation
Enterprise value is 18.98% above the market cap, as debt exceeds cash.
| Market Cap | $37.51B |
|---|---|
| Enterprise Value | $44.63B |
| Latest price (Nov 17, 2026) | $81.84 |
Key Dates
The next earnings report is expected on Feb 8, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Oct 23, 2026.
| Next Earnings Date | Feb 8, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 28, 2026 |
| Last Ex-Dividend Date | Oct 23, 2026 |
| Last Payment Date | Nov 13, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.7x and 3.2x. Its year-end P/E ranged from 17.0x to 19.6x from 2023 to 2025.
| P/E Ratio | 16.7x |
|---|---|
| Forward P/E | 16.0x |
| P/S Ratio | 1.7x |
| Forward P/S | 1.7x |
| P/B Ratio | 3.2x |
| P/FCF Ratio | 19.6x |
| P/OCF Ratio | 15.5x |
| PEG Ratio | 2.1 |
Enterprise Valuation
Counting debt and cash, the company is valued at 11.5x EBITDA and 23.4x free cash flow.
| EV / Earnings | 20.2x |
|---|---|
| EV / Sales | 2.1x |
| EV / EBITDA | 11.5x |
| EV / EBIT | 13.9x |
| EV / FCF | 23.4x |
Price Statistics
The stock is up 12.04% over 52 weeks and trades 15.09% above its 50-day average.
| Beta (1Y) | 0.64 |
|---|---|
| 52-Week Change | +12.04% |
| 1-Month Change | +17.38% |
| 3-Month Change | +9.74% |
| 6-Month Change | +32.98% |
| Total Return (1Y) | +12.24% |
| Total Return (3Y CAGR) | +4.05% |
| Return vs SPY (1Y) | +3.85% |
| Max Drawdown (1Y) | -32.47% |
| Max Drawdown (3Y) | -37.35% |
| Sharpe Ratio (1Y) | 0.40 |
| Correlation with SPY (1Y) | 0.25 |
| 50-Day Average | $71.11 |
| 200-Day Average | $69.91 |
| 52-Week Range | $58.68 to $89.59 |
| RSI (14 Days) | 63.5 |
| Average Volume (20 Days) | 4.34M |
Financial Position
Current assets cover 1.30x current liabilities, and total debt is 0.86x shareholder equity.
| Current Ratio | 1.30x |
|---|---|
| Quick Ratio | 1.01x |
| Debt / Equity | 0.86x |
| Debt / EBITDA | 2.60x |
| Debt / FCF | 5.28x |
| Interest Coverage | 7.32x |
Returns and Efficiency
Return on invested capital is 11.86% and return on equity is 19.02% over the last 12 months.
| Return on Equity (ROE) | 19.02% |
|---|---|
| Return on Assets (ROA) | 5.76% |
| Return on Invested Capital (ROIC) | 11.86% |
| Return on Capital Employed (ROCE) | 10.85% |
| ROE (5Y Average) | 20.49% |
| ROA (5Y Average) | 6.57% |
| Asset Turnover | 0.58x |
| Inventory Turnover | 5.08x |
| Receivables Turnover | 5.54x |
| Cash Conversion Cycle | 46 days |
Taxes
Income tax took 20.22% of pretax income over the last 12 months.
| Income Tax (TTM) | $560.00M |
|---|---|
| Effective Tax Rate | 20.22% |
Scores
GEHC has an Altman Z-Score of 2.01, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.01 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $21.64B over the last 12 months is up 6.87% from the 12 months before.
| Revenue | $21.64B |
|---|---|
| Revenue Growth (YoY) | +6.87% |
| Gross Profit | $8.64B |
| Operating Income | $2.89B |
| Pretax Income | $2.77B |
| Net Income | $2.21B |
| EBITDA | $3.83B |
| EBIT | $3.21B |
| Reported EPS (TTM) | $4.90 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 30.26% of the $38.37B in total assets.
| Cash and Equivalents | $2.85B |
|---|---|
| Total Debt | $9.97B |
| Net Debt | $7.12B |
| Net Debt Per Share | $15.75 |
| Working Capital | $2.68B |
| Shareholder Equity | $11.61B |
| Book Value Per Share | $25.69 |
| Tangible Book Value | -$5.34B |
| Total Assets | $38.37B |
| Total Liabilities | $26.51B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $526.00M of capital spending, operating cash flow left $1.89B of free cash flow.
| Operating Cash Flow | $2.42B |
|---|---|
| Capital Expenditures | $526.00M |
| Free Cash Flow | $1.89B |
| FCF Per Share | $4.18 |
| Depreciation and Amortization | $622.00M |
| Dividends Paid | $64.00M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 13.34%, against a 5-year average of 13.77%.
| Gross Margin | 39.94% |
|---|---|
| Operating Margin | 13.34% |
| Pretax Margin | 12.80% |
| Net Margin | 10.21% |
| EBITDA Margin | 17.70% |
| EBIT Margin | 14.83% |
| FCF Margin | 8.73% |
| Gross Margin (5Y Average) | 40.43% |
| Operating Margin (5Y Average) | 13.77% |
| Net Margin (5Y Average) | 10.58% |
Growth
Revenue grew 3.99% a year over 3 years, and EPS 2.77% a year.
| Revenue Growth (3Y CAGR) | +3.99% |
|---|---|
| Revenue Growth (5Y CAGR) | +3.74% |
| EPS Growth (3Y CAGR) | +2.77% |
| FCF Growth (3Y CAGR) | -5.84% |
| FCF Growth (5Y CAGR) | +1.06% |
| Operating Income Growth (3Y CAGR) | +3.09% |
| Book Value Per Share Growth (2Y CAGR) | +20.33% |
Dividends and Yields
GEHC pays out 2.71% of earnings as dividends.
| Dividend Per Share (Annual) | $0.16 |
|---|---|
| Dividend Yield | 0.20% |
| Payment Schedule | Quarterly |
| Payout Ratio | 2.71% |
| FCF Payout Ratio | 3.39% |
| Earnings Yield | 5.99% |
| FCF Yield | 5.11% |
| Buyback Yield | 0.75% |
| Shareholder Yield | 0.92% |
Peer Position
Against 11 similar companies, GEHC has the 9th highest P/E.
P/E RatioPeer median 22.0x
P/S RatioPeer median 3.6x
ROICPeer median 7.46%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +9.89%
Dividend YieldPeer median 0.00%
| P/E Ratio | 16.7x vs 22.0x median |
|---|---|
| P/S Ratio | 1.7x vs 3.6x median |
| ROIC | 11.86% vs 7.46% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +6.87% vs +9.89% median |
| Dividend Yield | 0.20% vs 0.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 5.44% and EPS growth at 9.61% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +5.44% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +9.61% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About GEHC
What is GEHC's market cap?
GE HealthCare Technologies has a market cap of $37.51B. Its enterprise value, which adds debt and subtracts cash, is $44.63B.
What is GEHC's P/E ratio?
GE HealthCare Technologies has a trailing P/E ratio of 16.7x and a forward P/E of 16.0x.
How many shares of GEHC are outstanding?
GE HealthCare Technologies has 452.00M shares outstanding. The count is down 0.88% from a year earlier.
Does GEHC pay a dividend?
Yes. GE HealthCare Technologies pays $0.16 a share a year, a dividend yield of 0.20%.
How much debt does GEHC have?
GE HealthCare Technologies has $9.97B of total debt and $2.85B of cash and equivalents, a net debt position of $7.12B.
GEHC pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors